Grants per year
Search results
-
Active
Development of a novel, RNA-interference-based therapeutic to treat prostate cancer
Peter, M. E. (PD/PI) & Murmann, A. E. (Co-Investigator)
NUAgo Therapeutics, Inc., National Cancer Institute
9/19/24 → 8/31/25
Project: Research project
-
Development of a DISE-inducing, short RNA therapeutic to treat solid cancers
Peter, M. E. (PD/PI), Bartom, E. T. (Co-Investigator), Kocherginsky, M. (Co-Investigator) & Murmann, A. E. (Co-Investigator)
8/1/24 → 7/31/25
Project: Research project
-
CCSG Program Leadership
Arispe, L. (Other), Backman, V. (Other), Godley, L. A. (Other), Hitsman, B. L. (Other), Khan, S. A. (Other), Matei, D. E. (Other), Munshi, H. G. (Other), Peter, M. E. (Other), Rini, C. (Other), Shilatifard, A. (Other), Simon, M. A. (Other), Stupp, R. (Other), Wignall, S. (Other), Woloschak, G. E. (Other), Yanez, B. R. (Other) & Zhang, B. (Other)
8/1/23 → 7/31/25
Project: Research project
-
Novel immune suppressive activities of Fas/CD95 in triple negative breast cancer
Peter, M. E. (PD/PI), Peter, M. E. (PD/PI), Bartom, E. T. (Co-Investigator) & Bartom, E. T. (Co-Investigator)
7/7/22 → 6/30/27
Project: Research project